SCHEMBL30801055

SCHEMBL30801055

CC(C)(C)OC(=O)c1cccc(CN(Cc2cc(O)cc(CN(Cc3cccc(C(=O)OC(C)(C)C)n3)Cc3cccc(C(=O)OC(C)(C)C)n3)n2)Cc2cccc(C(=O)OC(C)(C)C)n2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 7/20 0.37
CYP1A2 P05177 1/20 0.36
GABRA1 P14867 3/20 0.34
GABRG2 P18507 3/20 0.34
GABRB3 P28472 3/20 0.34
GABRA5 P31644 3/20 0.34
GABRA3 P34903 3/20 0.34
GABRA2 P47869 3/20 0.34
GABRA6 Q16445 3/20 0.34
GABRA4 P48169 2/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRB2 P47870 1/20 0.34
GABRE P78334 1/20 0.34
GABRG1 Q8N1C3 1/20 0.34
GABRG3 Q99928 1/20 0.34
GABRQ Q9UN88 1/20 0.34
NQO2 P16083 1/20 0.33
HPGDS O60760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27119074 1.00 MRGPRX4 (0.37) MRGPRX4CYP1A2GABRA1GABRG2GABRB3
SCHEMBL22451971 0.86 MRGPRX4 (0.49) MRGPRX4CYP1A2ALDH1A1
SCHEMBL26966747 0.84 PTGER1 (0.40) PDE5A
SCHEMBL23567539 0.84 NR1D1 (0.40) MRGPRX4CYP1A2GABRA1GABRG2GABRB3
SCHEMBL15865618 0.80 CYP1A2 (0.36) MRGPRX4CYP1A2GABRA1GABRG2GABRB3
SCHEMBL15865612 0.80 CYP1A2 (0.36) MRGPRX4CYP1A2GABRA1GABRG2GABRB3
SCHEMBL27152458 0.80 PPARG (0.39) PDE5A
SCHEMBL2352200 0.78 CYP1A2 (0.44) MRGPRX4CYP1A2GABRA1GABRG2GABRB3
SCHEMBL29844105 0.78 CYP1A2 (0.44) MRGPRX4CYP1A2GABRA1GABRG2GABRB3
SCHEMBL27119075 0.78 SUCNR1 (0.46) NQO2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044554-A1 VHH ANTIBODY CONJUGATES WITH HETEROARYL CHELATORS Abdera Therapeutics Inc. (US) 2024-02-29 WO disclosed